Radical Retroperitoneal Node Dissection after Chemotherapy for Testicular Tumours
- 1 June 1989
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 63 (6), 641-643
- https://doi.org/10.1111/j.1464-410x.1989.tb05262.x
Abstract
A group of 29 patients underwent salvage node dissection for residual retroperitoneal masses following orchiectomy and combination chemotherapy for advanced testicular cancer between 1980 and 1988. The results confirm that surgery for residual retroperitoneal masses following combination chemotherapy is worthwhile and whenever possible the sympathetic chain should be preserved.This publication has 14 references indexed in Scilit:
- Short‐course Etoposide, Bleomycin and Cisplatin in the Treatment of Metastatic Germ Cell Tumours. Appraisal of its Potential as Adjuvant Chemotherapy for Stage 1 Testis TumoursBritish Journal of Urology, 1988
- The Role of Surgery in the Combined Management of Metastases from Malignant Teratomas of TestisBritish Journal of Urology, 1987
- The Current Management of Testicular CancerBritish Journal of Urology, 1987
- Surgical Salvage of Advanced Testicular TumoursBritish Journal of Urology, 1987
- Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratomaBritish Journal of Cancer, 1984
- Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapyCancer, 1984
- The growing teratoma syndromeCancer, 1982
- Cytoreductive Surgery for Metastatic Testis Cancer: Tissue Analysis of Retroperitoneal Masses after ChemotherapyJournal of Urology, 1982
- Cytoreductive Surgery for Metastatic Testis Cancer: Considerations of Timing and ExtentJournal of Urology, 1980
- Retroperitoneal Lymph Node Dissection for Testicular TumorsJournal of Urology, 1959